Pomegra Wiki

Size-factor

The size factor is a systematic investment approach that overweights smaller companies and underweights larger ones, betting that small-cap stocks deliver superior long-term returns to compensate investors for their higher risk and lower liquidity.

For the broader factor framework, see factor investing. For value-focused small-cap strategies, see value-factor. For broad market exposure, see index-fund.

The small-cap premium

The size effect is a well-documented historical phenomenon: stocks of smaller companies have outperformed larger ones over many decades. Smaller companies offer higher growth potential, operate in less-efficient markets (less analyst coverage), and are riskier. This risk premium has historically rewarded small-cap investors.

However, the premium is inconsistent, has shrunk over time, and has been dominated by a handful of mega-cap stocks in recent decades.

Why small-cap exists

Several factors explain the historical small-cap premium:

  1. Risk premium. Smaller companies are riskier: less diversified, less stable, more vulnerable to recessions.
  2. Mispricing. Fewer analysts cover small-caps; less institutional interest means pricing inefficiencies persist longer.
  3. Growth potential. Smaller companies often have more runway for growth than mature large-caps.
  4. Inefficient markets. Small-cap stocks trade in less liquid, more inefficient markets, creating opportunities.

Implementation challenges

Small-cap investing has practical challenges:

  • Higher costs. Bid-ask spreads are wider, trading costs are higher, and turnover can be costly.
  • Tax drag. Frequent rebalancing within small-cap baskets triggers capital gains.
  • Liquidity risk. In stress, small-cap stocks become illiquid; exits can be difficult.
  • Concentration. A small-cap portfolio of 100 stocks can be heavily concentrated in a dozen or so winners.

The recent small-cap drought

From roughly 2007–2022, large-cap (particularly mega-cap technology) dramatically outperformed small-cap. A small-cap investor who bought in 2000 waited 20+ years for relative recovery. This illustrates the critical risk: even if small-cap outperformance exists on average, the timing can be brutal.

See also

Wider context